Biofocus expands diarrheal drug collaboration

Biofocus DPI and the Institute for Oneworld Health have announced that they have expanded its 2006 collaboration in diarrheal disease drug discovery.

Under the expanded collaboration, Biofocus DPI is performing a high-throughput, cell-based functional screen to identify potential new drugs for the treatment of diarrheal diseases.

The 'hits' identified in this screen will be confirmed through a series of activity assays developed by Biofocus DPI specifically for this drug target.

In 2006, Biofocus DPI and the Institute for Oneworld Health initiated a collaboration to develop new drugs against childhood diarrheal disease in developing countries.

During this initial collaboration, cell-based functional assays have been developed by Biofocus DPI to find small molecule compounds with potential activity against a specific diarrheal disease target.

Back to top